Nubia Capital Invests in Syndicate Bio to Advance Precision Medicine and Inclusive Genomic Research in Africa
At Nubia Capital, we are driven by a singular mission: to back visionary founders who are building essential infrastructure in underserved markets. Today, we are excited to announce our investment in Syndicate Bio, a cutting-edge precision medicine company developing the world’s richest and most diverse human genomic datasets, beginning with…